Description
- Abstract:
- Over the past several years, there have been hundreds of legal claims made against the makers of Mirena, the most popular intrauterine device (IUD) marketed and sold in the United States. Law firms have advertised to women on television, alleging that Bayer Healthcare Pharmaceuticals failed to warm consumers about the risks associated with Mirena and willingly sold a defective product. These legal claims are juxtaposed against a contraceptive landscape in which IUDs, and Mirena in particular, are gaining a significant role in preventing unwanted pregnancies. The Centers for Disease Control and Prevention estimates that 6.4 percent of American women ages 15 to 44 years used an IUD from 2011 to 2013. A historical precedent for legal action against IUDs exists in the class action lawsuit against the injurious Dalkon Shield IUD in the 1970s. This research project aims to describe the tenor of the Mirena lawsuits, review the published literature on IUD perforation rates, explore the adverse events data reported to the Food and Drug Administration (FDA), examine Mirena\u2019s labeling, and discuss the relevant and influential factors that regarding the lawsuits.
- Notes:
- Scholarly concentration: Women's Reproductive Health
Access Conditions
- Use and Reproduction
-
- This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License
Citation
Dunlap, Rachel R., and Adashi, Eli A.,
"Under the shadow of the Dalkon Shield: assessing the allegations against the Mirena IUD"
(2016).
Scholarly Concentrations Program Collection of Abstracts.
Brown Digital Repository. Brown University Library.
https://doi.org/10.26300/v6q7-8w87
Relations
Collection:
-
Scholarly Concentrations Program Collection of Abstracts
...Each spring the Warren Alpert Medical School of Brown University Scholarly Concentrations Program (SCP) publishes a print volume of abstracts written by medical students in the SCP and their mentors that describes the research projects that they collaborated on over …